XLV, the Health Care Select Sector SPDR ETF, closes out June with its short interest at a fresh high and borrow availability at its tightest level since the rally began — even as the fund itself just posted its best month in several weeks.
The short interest build is the defining development since the June 24 note. Shorts now account for 5.35% of the float, roughly 13.9 million shares — up 31.5% on the week and 40% over the past month. That eclipses the previous peaks flagged in prior coverage. The pace of accumulation has been notable: from roughly 9.5 million shares in mid-June to nearly 14 million by month-end, the rebuild has been almost uninterrupted. The ORTEX short score reflects this pressure, climbing to 49.2 as of June 30, up from 43.9 on June 17 — not extreme territory, but the direction of travel is clear.
Borrow conditions have tightened with the short interest build, though the overall picture remains manageable. Availability has dropped sharply from over 2,100% in late May to 222% now — still comfortably in normal territory, but well below where it was just a month ago. That compares to a 52-week tightest reading of 24.2%, so there is room for further compression before borrows become genuinely constrained. Cost to borrow eased back to 0.46% on June 30 after touching 0.67% on June 22, so the week ended with some relief on the borrow cost side even as the short count itself kept rising. Overall, the lending market reads as tightening but not distressed.
Options positioning adds a layer of caution to the picture. The put/call ratio closed the week at 1.35, modestly above its 20-day average of 1.29 — a z-score of just under one — suggesting hedging demand is running slightly above normal but nowhere near the defensive extremes the fund has seen this year. The 52-week high on the PCR is 2.67, so current levels reflect mild rather than acute defensiveness. The divergence flagged in the June 24 note — shorts building while put buyers were stepping back — has partially resolved: both signals are now pointing in a cautious direction, though neither is at an extreme.
The price action complicates the short thesis. XLV gained 4.3% on the week and 6.1% over the past month, closing at $158.66. Shorts have been adding into a rising tape, which increases the risk of a squeeze if healthcare sentiment holds. The 52-week utilization high of 94.45% underscores how much room there is for the borrow market to tighten further if the fund keeps attracting short interest at its current pace.
What to watch: whether the short interest build continues into the new week or whether month-end positioning effects reverse some of the June accumulation — and whether the improving price trend forces any of the newly added shorts to cover.
See the live data behind this article on ORTEX.
Open XLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
